Healthcare -
Biotechnology - NASDAQ - US
$ 43.33
-0.161 %
$ 4 B
Market Cap
-6.82
P/E
RARE - DEPRECIATION & AMORTIZATION
Depreciation & Amortization RARE - Ultragenyx Pharmaceutical Inc.
26 M
LAST VALUE
40.16%
2 YEAR CAGR
5.89%
5 YEAR CAGR
50.23%
10 YEAR CAGR